Saturday 17 October 2026
Export ABPO’s income statement to Excel — free account
Abpro Holdings Inc.
ABPO Healthcare Biotechnology
Abpro Holdings Inc.’s revenue for fiscal 2024 (year ended December 2024) was $183,000.00, up 50.0% from fiscal 2023. In the quarter to June 2026, EPS grew 89.3% and free cash flow was flat, each against the same quarter a year earlier.
0.36
0.05
−12.20%
Follow ABPO
| Dec '17 | Jan '21 | Dec '21 | Jan '22 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | — | 0.00 | 0.00 | — |
P/S ratio |
— | — | — | — | — | 0.00 | 0.00 | — |
Altman Z-Score |
— | — | — | — | — | (60.53) | (44.65) | — |
Altman Z″-Score (non-manufacturers) |
— | — | — | — | — | (157.12) | (118.59) | — |
P/FCF ratio |
— | — | — | — | — | 0.00 | 0.00 | — |
Beneish M-Score |
— | — | — | — | — | — | 0.02 | — |
P/Operating CF |
— | — | — | — | — | (34.30) | (10.98) | — |
P/B ratio |
— | — | — | — | — | 0.00 | 0.00 | — |
Price to Tangible BV |
— | — | — | — | — | 0.00 | 0.00 | — |
EV/Sales |
— | — | — | — | — | 0.00 | 0.00 | — |
EV/EBITDA |
— | — | — | — | — | 0.00 | 0.00 | — |
EV/Operating CF |
— | — | — | — | — | (27.20) | (4.31) | — |
EV/FCF |
— | — | — | — | — | (27.03) | (4.28) | — |
Quick Ratio |
— | 0.00 | 0.00 | 0.18 | 0.18 | 0.06 | 0.16 | 0.03 |
Current Ratio |
— | 0.00 | 0.00 | 0.36 | 0.36 | 0.13 | 0.19 | 0.10 |
Net Debt/EBITDA |
— | (55.72) | — | 0.16 | 0.19 | 0.08 | 0.32 | 0.01 |
Debt/Assets |
0.00% | 27.75% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | 4.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.00 |
Operating CF/Net income |
— | 0.00 | — | (1.34) | (1.34) | 0.63 | 0.52 | 2.08 |
Capex/Depreciation |
— | — | — | — | — | (0.06) | 0.00 | 0.04 |
Interest Coverage |
— | — | — | 0.00 | — | (510.70) | (25.64) | (7.49) |
| — | 0.00% | 0.00% | 0.00% | (15.90%) | 23.50% | 33.68% | 24.90% | |
| — | (1.00%) | 0.00% | 0.00% | 0.57% | (7.46%) | (434.36%) | (101.05%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
— | 0.53% | 0.00% | (64.64%) | (64.64%) | 86.08% | 110.23% | 34.23% |
Average Days of Receivables |
— | — | — | — | — | 263.28 | 365.00 | 0.00 |
Research and Development Expense of Revenue |
— | — | — | — | — | 3,496.72% | 1,630.05% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | — | 0.00% | — | 6,231.15% | 3,891.26% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.04 | 0.16 |
Share Based Compensation of Revenue |
— | — | — | — | 0.00% | 1,889.34% | 1,053.01% | 0.00% |
Graham Net Nets |
— | — | — | — | — | (0.44) | (0.38) | — |
Graham Number |
— | — | — | — | — | 240.14 | 63.22 | — |
Earnings Yield |
— | — | — | — | — | (5.82%) | (17.27%) | — |
Free Cash Flow Yield |
— | — | — | — | — | (3.68%) | (21.67%) | — |
Revenue per Share |
— | 0.00 | — | 0.00 | 0.00 | 0.19 | 0.23 | 0.00 |
Operating CF per Share |
— | 0.00 | — | (0.03) | (4.74) | (11.62) | (11.58) | (2.69) |
Capex per Share |
— | 0.00 | — | 0.00 | 0.00 | (0.08) | 0.00 | 0.01 |
Free Cash Flow per Share |
— | 0.00 | — | (0.03) | (4.74) | (11.69) | (11.58) | (2.68) |
Cash per Share |
— | 0.00 | — | 0.01 | 1.57 | 1.35 | 3.84 | 0.04 |
Shareholders Equity per Share |
— | 0.00 | 0.00 | 7.94 | (44.75) | (138.81) | (19.16) | (3.71) |
Interest Debt per Share |
— | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.00 | 0.00 | 7.94 | (44.75) | (138.81) | (19.16) | (3.71) |
Free Cash Flow |
— | — | — | (1.18) | (1.18) | (7.45) | (9.03) | (5.98) |
Working Capital |
— | (0.34) | (0.34) | (1.37) | (1.37) | (13.70) | (15.83) | (8.45) |
Capital Expenditures |
— | — | — | — | — | (0.05) | — | 0.03 |
Net Current Asset Value |
— | (0.34) | (0.34) | (11.87) | (320.97) | (89.75) | (15.83) | (8.45) |
EV/EBIT |
— | — | — | — | — | 0.00 | 0.00 | — |
Capex to Sales |
— | — | — | — | — | 0.39 | 0.00 | 0.00 |
Price to Operating Income |
— | — | — | — | — | 0.00 | 0.00 | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
— | — | — | — | — | 7.76 | 16.81 | 0.00 |
Cash ROIC |
— | 0.00% | 0.00% | (0.40%) | 10.99% | 8.51% | 75.54% | 72.93% |
Accounts Receivable Turnover |
— | — | — | — | — | 0.00 | 1.35 | 0.00 |
Accounts Payable Turnover |
— | — | — | — | — | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | — | — | — | — | 0.14 | 0.18 |
Average Payables |
— | — | — | — | — | 4.58 | 5.93 | 4.63 |
Average Assets |
— | 0.18 | 0.36 | 155.46 | 155.46 | 156.96 | 4.01 | 2.86 |
Average Common Equity |
— | — | 0.02 | 148.97 | (5.58) | (49.81) | (51.69) | (11.61) |
Columns are period end dates